Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -321,545 | -111,399 | -278,482 | -180,091 | -169,431 |
| Depreciation Amortization | 40,745 | 32,792 | 21,641 | 25,996 | 35,057 |
| Accounts receivable | -6,001 | -11,264 | -1,060 | 853 | 2,301 |
| Accounts payable and accrued liabilities | -17,563 | 24,763 | 2,055 | 2,467 | -6,036 |
| Other Working Capital | -63,020 | -25,475 | 875 | 80,775 | -26,042 |
| Other Operating Activity | 129,909 | -189,438 | 68,680 | 55,208 | 121,408 |
| Operating Cash Flow | $-237,475 | $-280,021 | $-186,291 | $-14,792 | $-42,743 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 200,577 | -109,367 | -3,396 | -113,472 | 58,518 |
| PPE Investments | N/A | N/A | N/A | -5,101 | -6,767 |
| Purchase Sale Intangibles | -36,212 | -41,591 | -28,366 | -19,050 | -17,799 |
| Other Investing Activity | -101,252 | 165,143 | -29,157 | -19,050 | -113,078 |
| Investing Cash Flow | $99,325 | $55,776 | $-32,553 | $-137,623 | $-61,327 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 104,926 | N/A | N/A |
| Common Stock Issued | 139,190 | 219,068 | 24,130 | 237,775 | 135,415 |
| Other Financing Activity | 232 | -316 | -11,483 | -6,092 | -7,702 |
| Financing Cash Flow | $139,422 | $218,752 | $117,573 | $231,683 | $127,713 |
| Exchange Rate Effect | -913 | 1,981 | -2,794 | 1,713 | -1,307 |
| Beginning Cash Position | 58,176 | 61,688 | 165,753 | 84,772 | 62,436 |
| End Cash Position | 58,535 | 58,176 | 61,688 | 165,753 | 84,772 |
| Net Cash Flow | $359 | $-3,512 | $-104,065 | $80,981 | $22,336 |
| Free Cash Flow | |||||
| Operating Cash Flow | -237,475 | -280,021 | -186,291 | -14,792 | -42,743 |
| Capital Expenditure | N/A | N/A | N/A | -5,101 | -6,767 |
| Free Cash Flow | -237,475 | -280,021 | -186,291 | -19,893 | -49,510 |